LICENSE AGREEMENTLicense Agreement • December 9th, 2020 • Miragen Therapeutics, Inc. • Services-medical laboratories • New York
THIS LICENSE AGREEMENT (“Agreement”) is made effective as of the 12th day of October, 2020 (the “Effective Date”), by and between Viridian Therapeutics, Inc., a Delaware corporation with a place of business at 213 Crescent St., Building 17, Suite 102B, Waltham, MA 02453 (“Licensee”) and ImmunoGen, Inc., a Massachusetts corporation with offices at 830 Winter Street, Waltham, MA 02451-1477, USA (“ImmunoGen”). Licensee and ImmunoGen may, from time-to-time, be individually referred to as a “Party” and collectively referred to as the “Parties”.
